Cadmium-mediated Lung Injury is Exacerbated by the Persistence of Classically Activated Macrophages
Overview
Affiliations
Heavy metals released into the environment have a significant effect on respiratory health. Lung macrophages are important in mounting an inflammatory response to injury, but they are also involved in repair of injury. Macrophages develop mixed phenotypes in complex pathological conditions and polarize to a predominant phenotype depending on the duration and stage of injury and/or repair. Little is known about the reprogramming required for lung macrophages to switch between these divergent functions; therefore, understanding the mechanism(s) by which macrophages promote metabolic reprogramming to regulate lung injury is essential. Here, we show that lung macrophages polarize to a pro-inflammatory, classically activated phenotype after cadmium-mediated lung injury. Because metabolic adaptation provides energy for the diverse macrophage functions, these classically activated macrophages show metabolic reprogramming to glycolysis. RNA-Seq revealed up-regulation of glycolytic enzymes and transcription factors regulating glycolytic flux in lung macrophages from cadmium-exposed mice. Moreover, cadmium exposure promoted increased macrophage glycolytic function with enhanced extracellular acidification rate, glycolytic metabolites, and lactate excretion. These observations suggest that cadmium mediates the persistence of classically activated lung macrophages to exacerbate lung injury.
Heavy metals: toxicity and human health effects.
Jomova K, Alomar S, Nepovimova E, Kuca K, Valko M Arch Toxicol. 2024; 99(1):153-209.
PMID: 39567405 PMC: 11742009. DOI: 10.1007/s00204-024-03903-2.
The Protective Effects of Active Peptide GLP4 on Lung Injury Induced by Cadmium Poisoning in Mice.
Zhu S, Wang X, Liu G Toxics. 2024; 12(6).
PMID: 38922058 PMC: 11209525. DOI: 10.3390/toxics12060378.
Nofal A, AboShabaan H, Fayyad R, Ereba R, Omar N, Elsharkawy S Front Immunol. 2023; 14:1297315.
PMID: 38094291 PMC: 10716534. DOI: 10.3389/fimmu.2023.1297315.
Alruhaimi R, Hassanein E, Bin-Jumah M, Mahmoud A Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(4):2335-2345.
PMID: 37819390 DOI: 10.1007/s00210-023-02754-5.
Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis.
Larson-Casey J, Saleem K, Surolia R, Pandey J, Mack M, Antony V J Immunol. 2023; 211(11):1714-1724.
PMID: 37782053 PMC: 10843506. DOI: 10.4049/jimmunol.2300053.